Monitoring changes in quality of life in patients with lung cancer under treatment with chemotherapy and co administration of zoledronic acid by using specialized questionnaires

Background: Due to the severity of the primary disease in patients with lung cancer, quality of life (QoL) is often overlooked. Factors that form QoL should be taken in consideration when planning the appropriate treatment and determining therapy targets, because of the increasing frequency of bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremmas, Ioannis, Petsatodis, George, Potoupnis, Michael, Laskou, Stella, Giannakidis, Dimitrios, Mantalovas, Stylianos, Koulouris, Charilaos, Katsaounis, Athanasios, Pavlidis, Efstathios, Amaniti, Aikaterini, Huang, Haidong, Bai, Chong, Shi, Dongchen, Dardas, Athanasios, Zarogoulidis, Paul, Sardeli, Chrisanthi, Konstantinou, Fotis, Katsikogiannis, Nikolaos, Zarogoulidis, Konstantinos, Karapantzos, Ilias, Karapantzou, Chrysanthi, Shen, Xiaping, Kesisoglou, Isaak, Sapalidis, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968760/
https://www.ncbi.nlm.nih.gov/pubmed/29805698
http://dx.doi.org/10.7150/jca.24785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968760/
https://www.ncbi.nlm.nih.gov/pubmed/29805698
http://dx.doi.org/10.7150/jca.24785

Ejemplares similares